The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
INK4 proteins, a family of mammalian CDK inhibitors with novel biological functions
Open accessAbstract
The cyclin D‐Cdk4‐6/INK4/Rb/E2F pathway plays a key role in controlling cell growth by integrating multiple mitogenic and antimitogenic stimuli. The members of INK4 family, comprising p16INK4a, p15INK4b, p18INK4c, and p19INK4d, block the progression of the cell cycle by binding to either Cdk4 or Cdk6 and inhibiting the action of cyclin D. These INK4 proteins share a similar structure dominated by several ankyrin repeats. Although they appear to be structurally redundant and equally potent as inhibitors, the INK4 family members are differentially expressed during mouse development. The striking diversity in the pattern of expression of INK4 genes suggested that this family of cell cycle inhibitors might have cell lineage‐specific or tissue‐specific functions. The INK4 proteins are commonly lost or inactivated by mutations in diverse types of cancer, and they represent established or candidate tumor suppressors. Apart from their capacity to arrest cells in the G1‐phase of the cell cycle they have been shown to participate in an increasing number of cellular processes. Given their emerging roles in fundamental physiological as well as pathological processes, it is interesting to explore the diverse roles for the individual INK4 family members in different functions other than cell cycle regulation. Extensive studies, over the past few years, uncover the involvement of INK4 proteins in senescence, apoptosis, DNA repair, and multistep oncogenesis. We will focus the discussion here on these unexpected issues. iubmb Life, 59: 419‐426, 2007
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Oncogenic activity of Cdc6 through repression of the INK4/ARF locus
Gonzalez, S., Klatt, P., Delgado, S., Conde, E., Lopez-Rios, F., Sanchez-Cespedes, M., Mendez, J., Antequera, F., & Serrano, M. (2006) · Nature · doi:10.1038/nature04585 · Cited by 186
RetractedCDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
Sancar, A., Lindsey-Boltz, L. A., Ünsal-Kaçmaz, K., & Linn, S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073723 · Cited by 3,317
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379 · cited 1×
“However, the senescence checkpoint is also considered to be a major mechanism for suppressing tumors, protecting the organism from cancer during early life ( 30 ).”
BackgroundA gene hypermethylation profile of human cancer.
Esteller, M., Corn, P. G., Baylin, S. B., & Herman, J. G. (2001) · PubMed · Cited by 2,032
Ink4a/Arf expression is a biomarker of aging
Krishnamurthy, J., Torrice, C., Ramsey, M. R., Kovalev, G. I., Al-Regaiey, K., Su, L., & Sharpless, N. E. (2004) · Journal of Clinical Investigation · doi:10.1172/jci22475 · Cited by 1,486
Senescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482 · cited 1×
“Although the stability of senescence presumably contributes to its anti-neoplasic activities, the molecular machinery that drives the cell into a permanent state of proliferative arrest is poorly understood ( 34 ).”
BackgroundTo cycle or not to cycle: a critical decision in cancer
Malumbres, M., & Barbacid, M. (2001) · Nature Reviews Cancer · doi:10.1038/35106065 · Cited by 1,468
Oxidant signals and oxidative stress
Finkel, T. (2003) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(03)00002-4 · Cited by 1,393
G1 cell-cycle control and cancer
Massagué, J. (2004) · Nature · doi:10.1038/nature03094 · Cited by 1,224
Sibling rivalry in the E2F family
Trimarchi, J. M., & Lees, J. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm714 · Cited by 1,158
Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a
Janzen, V., Forkert, R., Fleming, H. E., Saito, Y., Waring, M. T., Dombkowski, D. M., Cheng, T., DePinho, R. A., Sharpless, N. E., & Scadden, D. T. (2006) · Nature · doi:10.1038/nature05159 · Cited by 1,106
ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks
Jazayeri, A., Falck, J., Lukas, C., Bartek, J., Smith, G. C. M., Lukas, J., & Jackson, S. P. (2006) · Nature Cell Biology · doi:10.1038/ncb1337 · Cited by 1,064
Harbour, J. W., Luo, R. X., Santi, A. D., Postigo, A. A., & Dean, D. C. (1999) · Cell · doi:10.1016/s0092-8674(00)81519-6 · Cited by 1,057
The signals and pathways activating cellular senescence
Ben-Porath, I., & Weinberg, R. A. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.013 · Cited by 1,046 · cited 2×
“In addition to telomere attrition, several other mechanisms can abruptly induce senescence independently of telomere length, termed ‘premature senescence’, including, overactivation of mitogenic pathways such as Ras, Raf, or MEK, or overexpression of E2F ( 32 ).”
BackgroundThe Regulation of INK4/ARF in Cancer and Aging
Kim, W. Y., & Sharpless, N. E. (2006) · Cell · doi:10.1016/j.cell.2006.10.003 · Cited by 1,009 · cited 2×
“ARF binds to and inactivates the MDM2 protein, and MDM2 in turn negatively regulates p53 ( 9 ).”
Backgroundp16INK4a induces an age-dependent decline in islet regenerative potential
Krishnamurthy, J., Ramsey, M. R., Ligon, K. L., Torrice, C., Koh, A., Bonner-Weir, S., & Sharpless, N. E. (2006) · Nature · doi:10.1038/nature05092 · Cited by 1,003
Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing
Molofsky, A. V., Slutsky, S. G., Joseph, N. M., He, S., Pardal, R., Krishnamurthy, J., Sharpless, N. E., & Morrison, S. J. (2006) · Nature · doi:10.1038/nature05091 · Cited by 972 · cited 1×
“These papers, using p16 INK4a -deficient and overexpressing mice to study self-renewal in three distinct tissues: hemoatopoietic stem cells (HSC), neural stem cells (NSC), and pancreatic islets, have suggested that p16 INK4a expression is one cause of aging in these tissues ( 49 – 51 ).”
The p16INK4a/CDKN2A tumor suppressor and its relatives
Ruas, M., & Peters, G. (1998) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(98)00017-1 · Cited by 911
Bracken, A. P., Kleine-Kohlbrecher, D., Dietrich, N., Pasini, D., Gargiulo, G., Beekman, C., Theilgaard-Mönch, K., Minucci, S., Porse, B. T., Marine, J.-C., et al. (2007) · Genes & Development · doi:10.1101/gad.415507 · Cited by 850
Regulation of the INK4b–ARF–INK4a tumour suppressor locus: all for one or one for all
Gil, J., & Peters, G. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1987 · Cited by 843 · cited 1×
“Detailed description of the elements and factors involved in INK4 transcription has been recently reviewed ( 6, 25 ).”
BackgroundCyclin D-dependent kinases, INK4 inhibitors and cancer
Ortega, S., Malumbres, M., & Barbacid, M. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00037-9 · Cited by 778
Norbury, C. J., & Zhivotovsky, B. (2004) · Oncogene · doi:10.1038/sj.onc.1207532 · Cited by 701
Zhang, R., Poustovoitov, M. V., Ye, X., Santos, H. A., Chen, W., Daganzo, S. M., Erzberger, J. P., Serebriiskii, I. G., Canutescu, A. A., Dunbrack, R. L., et al. (2005) · Developmental Cell · doi:10.1016/j.devcel.2004.10.019 · Cited by 699
Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence
Ohtani, N., Zebedee, Z., Huot, T. J. G., Stinson, J. A., Sugimoto, M., Ohashi, Y., Sharrocks, A. D., Peters, G., & Hara, E. (2001) · Nature · doi:10.1038/35059131 · Cited by 654
A novel role for high-mobility group A proteins in cellular senescence and heterochromatin formation
Narita, M., Narita, M., Krizhanovsky, V., Nuñez, S., Chicas, A., Hearn, S. A., Myers, M. P., & Lowe, S. W. (2006) · Cell · doi:10.1016/j.cell.2006.05.052 · Cited by 629
Bardeesy, N., Aguirre, A. J., Chu, G. C., Cheng, K.-H., Lopez, L. V., Hezel, A. F., Feng, B., Brennan, C., Weissleder, R., Mahmood, U., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601273103 · Cited by 581
Zindy, F., Quelle, D. E., Roussel, M. F., & Sherr, C. J. (1997) · Oncogene · doi:10.1038/sj.onc.1201178 · Cited by 574
p16 INK4A is a robust in vivo biomarker of cellular aging in human skin
Ressler, S., Bartkova, J., Niederegger, H., Bartek, J., Scharffetter‐Kochanek, K., Jansen‐Dürr, P., & Wlaschek, M. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00231.x · Cited by 557
Takahashi, A., Ohtani, N., Yamakoshi, K., Iida, S.-I., Tahara, H., Nakayama, K., Nakayama, K. I., Ide, T., Saya, H., & Hara, E. (2006) · Nature Cell Biology · doi:10.1038/ncb1491 · Cited by 528
Bernstein, C. (2002) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(02)00009-1 · Cited by 527
Cancer and ageing: rival demons?
Campisi, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1073 · Cited by 512 · cited 1×
“Although it ensures tissue repair and regeneration, it also puts tissues at risk of hyperproliferative diseases, the most deadly of which is cancer ( 47 ).”
BackgroundMolecular dissection of formation of senescence-associated heterochromatin foci
Zhang, R., Chen, W., & Adams, P. D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02019-06 · Cited by 415
The INK4 family of cell cycle inhibitors in cancer
Roussel, M. F. (1999) · Oncogene · doi:10.1038/sj.onc.1202998 · Cited by 322
Apoptosis and genomic instability
Zhivotovsky, B., & Kroemer, G. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1443 · Cited by 299
Telomeres, aging and cancer: In search of a happy ending
Kim, S.-H., Kaminker, P., & Campisi, J. (2002) · Oncogene · doi:10.1038/sj.onc.1205077 · Cited by 230
Murphy, N. C., Ring, M., Heffron, C. C. B. B., King, B., Killalea, A. G., Hughes, C., Martin, C. M., McGuinness, E. P. J., Sheils, O. M., & O’Leary, J. J. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2004.018895 · Cited by 228
The differential impact of p16INK4a or p19ARF deficiency on cell growth and tumorigenesis
Sharpless, N. E., Ramsey, M. R., Balasubramanian, P., Castrillon, D. H., & DePinho, R. A. (2004) · Oncogene · doi:10.1038/sj.onc.1207074 · Cited by 224
Karakaidos, P., Taraviras, S., Vassiliou, L. V., Zacharatos, P., Kastrinakis, N. G., Kougiou, D., Kouloukoussa, M., Nishitani, H., Papavassiliou, A. G., Lygerou, Z., et al. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63393-7 · Cited by 180
Aggerholm, A., Holm, M. S., Guldberg, P., Olesen, L. H., & Hokland, P. (2006) · European Journal of Haematology · doi:10.1111/j.1600-0609.2005.00559.x · Cited by 176
Uziel, T., Zindy, F., Xie, S., Lee, Y., Forget, A., Magdaleno, S. M., Rehg, J. E., Calabrese, C. R., Solecki, D. J., Eberhart, C. G., et al. (2005) · Genes & Development · doi:10.1101/gad.1368605 · Cited by 159
Biochemical and cellular mechanisms of mammalian CDK inhibitors: a few unresolved issues
Pei, X.-H., & Xiong, Y. (2005) · Oncogene · doi:10.1038/sj.onc.1208611 · Cited by 158
Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging
Matheu, A., Pantoja, C., Efeyan, A., Criado, L. M., Martín‐Caballero, J., Flores, J. M., Klatt, P., & Serrano, M. (2004) · Genes & Development · doi:10.1101/gad.310304 · Cited by 156
INK4d-Deficient Mice Are Fertile Despite Testicular Atrophy
Zindy, F., van Deursen, J., Grosveld, G. C., Sherr, C. J., & Roussel, M. F. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.1.372-378.2000 · Cited by 144
Zindy, F., den Besten, W., Chen, B., Rehg, J. E., Latres, E., Barbacid, M., Pollard, J. W., Sherr, C. J., Cohen, P. E., & Roussel, M. F. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.9.3244-3255.2001 · Cited by 131
Haploinsufficiency of p18INK4c Sensitizes Mice to Carcinogen-Induced Tumorigenesis
Bai, F., Pei, X., Godfrey, V., & Xiong, Y. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.4.1269-1277.2003 · Cited by 105
Increased stability of the p16 mRNA with replicative senescence
Wang, W., Martindale, J. L., Yang, X., Chrest, F. J., & Gorospe, M. (2005) · The EMBO Reports · doi:10.1038/sj.embor.7400346 · Cited by 101
Convergence of vitamin D and retinoic acid signalling at a common hormone response element
Tavera-Mendoza, L. E., Wang, T. T., Lallemant, B., Zhang, R., Nagai, Y., Bourdeau, V., Calderon, M. R., Desbarats, J., Mader, S., & White, J. H. (2005) · EMBO Reports · doi:10.1038/sj.embor.7400594 · Cited by 100
Apoptotic Signaling in Response to a Single Type of DNA Lesion, O6-Methylguanine
Hickman, M. J., & Samson, L. D. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00162-5 · Cited by 92
Raaphorst, F. M. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi111 · Cited by 89
Almohanna, M., Manogaran, P. S., AL‐MUKHALAFI, Z., Al‐Hussein, K., & Aboussekhra, A. (2004) · Oncogene · doi:10.1038/sj.onc.1206927 · Cited by 82
Ceruti, J. M., Scassa, M. É., Fló, J., Varone, C. L., & Cánepa, E. T. (2005) · Oncogene · doi:10.1038/sj.onc.1208570 · Cited by 58
Self-citationBártková, J., Thullberg, M., Meyts, E. R., Skakkebæk, N. E., & Bartek, J. (2000) · Oncogene · doi:10.1038/sj.onc.1203769 · Cited by 55
Le, H.-V., Minn, A. J., & Massagué, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504689200 · Cited by 51
Zhu, D., Xu, G., Ghandhi, S., & Hubbard, K. (2002) · Journal of Cellular Physiology · doi:10.1002/jcp.10147 · Cited by 49
Cell Cycle Requirements in Assembling Silent Chromatin in Saccharomyces cerevisiae
Kirchmaier, A. L., & Rine, J. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.3.852-862.2006 · Cited by 48
Stem cell: balancing aging and cancer
Krtolica, A. (2004) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.007 · Cited by 47
Virchis, A. E., GANESHAGURU, K., Hart, S., Jones, D. T., Fletcher, L., Wright, F., Wickremasinghe, R. G., Man, A., Csermak, K., Meyer, T., et al. (2002) · The Hematology Journal · doi:10.1038/sj.thj.6200165 · Cited by 39
Scassa, M. É., Marazita, M. C., Ceruti, J. M., Carcagno, A. L., Sirkin, P. F., González‐Cid, M., Pignataro, O. P., & Cánepa, E. T. (2007) · DNA repair · doi:10.1016/j.dnarep.2006.12.003 · Cited by 29
Self-citationThe tumor suppressor p16Ink4a regulates T lymphocyte survival
Bianchi, T., Rufer, N., MacDonald, H. R., & Migliaccio, M. (2006) · Oncogene · doi:10.1038/sj.onc.1209437 · Cited by 27
Tavera-Mendoza, L. E., Wang, T. T., & White, J. H. (2006) · Cell Cycle · doi:10.4161/cc.5.6.2585 · Cited by 25
Activation of protein kinase C promotes human cancer cell growth through downregulation of p18INK4c
Matsuzaki, Y., Takaoka, Y., Hitomi, T., Nishino, H., & Sakai, T. (2004) · Oncogene · doi:10.1038/sj.onc.1207702 · Cited by 23
Cited by
Wilken, R., Veena, M. S., Wang, M. B., & Srivatsan, E. S. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-12 · Cited by 1,066
Salminen, A., Kauppinen, A., & Kaarniranta, K. (2012) · Cellular Signalling · doi:10.1016/j.cellsig.2011.12.006 · Cited by 763
Romagosa, C., Simonetti, S., López-Vicente, L., Mazo, A., Lleonart, M. E., Castellvi, J., & Ramon y Cajal, S. (2011) · Oncogene · doi:10.1038/onc.2010.614 · Cited by 509
Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs
Roskoski, R. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2018.11.035 · Cited by 393
Regulation of B-cell proliferation and differentiation by pre-B-cell receptor signalling
Herzog, S., Reth, M., & Jumaa, H. (2009) · Nature Reviews Immunology · doi:10.1038/nri2491 · Cited by 357
Metadata
- Authors
- Cánepa, E. T., Scassa, M. E., Ceruti, J. M., Marazita, M. C., Carcagno, A. L., Sirkin, P. F., & Ogara, M. F.
- Venue
- IUBMB Life
- Publisher
- Wiley
- Published
- 2007-01
- Volume
- 59
- Issue
- 7
- Pages
- 419-426
- ISSN
- 1521-6543 (ISSN-L)
- 1521-6551
- OpenAlex
- W2079651105
- Cited by
- 312
- References
- 62
- FWCI
- 6.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.